OrganiGram Holdings Inc

Healthcare CA OGI

1.61CAD
0.06(3.87%)

Last update at 2025-05-09T16:45:00Z

Day Range

1.551.62
LowHigh

52 Week Range

1.613.95
LowHigh

Fundamentals

  • Previous Close 1.55
  • Market Cap234.52M
  • Volume57676
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-25.36523M
  • Revenue TTM149.21M
  • Revenue Per Share TTM1.83
  • Gross Profit TTM 31.57M
  • Diluted EPS TTM-2.51

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-09-30 2022-09-30 2022-08-31 2021-09-30 2021-08-31
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2022-08-31 2021-09-30 2021-08-31
Income before tax -232.07062M -14.37100M -14.37100M -130.70400M -130.70400M
Minority interest - - - - -
Net income -229.47861M -14.28300M -14.28300M -132.54600M -184.49100M
Selling general administrative 48.95M 42.35M 42.35M 30.72M 30.72M
Selling and marketing expenses 17.86M 16.86M 16.86M 15.81M 15.81M
Gross profit -33.80688M 31.57M 31.57M -28.39900M -28.39900M
Reconciled depreciation - 24.91M 24.91M 31.03M 31.03M
Ebit -112.40437M -40.11600M -38.75200M -73.95700M -91.82000M
Ebitda -88.23075M -15.20900M -15.20900M -42.92400M -42.92400M
Depreciation and amortization 24.17M 24.91M 23.54M 31.03M 48.90M
Non operating income net other - - - - -
Operating income -112.40437M -38.75200M -38.75200M -91.82000M -91.82000M
Other operating expenses 261.61M 184.56M 184.56M 152.00M 152.00M
Interest expense 0.28M 0.43M 0.43M 2.96M 2.96M
Tax provision - -0.08800M -0.08800M 0.00000M 0.00000M
Interest income - 32.34M 32.34M 33.05M 33.05M
Net interest income - -0.42900M -0.42900M -2.96000M -2.96000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -3.51878M -0.08800M -0.08800M 1.84M 53.79M
Total revenue 149.21M 145.81M 145.81M 79.16M 79.16M
Total operating expenses 78.60M 70.32M 70.32M 44.44M 44.44M
Cost of revenue 183.01M 114.24M 114.24M 107.56M 107.56M
Total other income expense net -119.66625M 24.38M 24.38M -38.88400M -38.88400M
Discontinued operations - - - - -
Net income from continuing ops - -14.28300M -14.28300M -130.70400M -130.70400M
Net income applicable to common shares - -14.28300M -14.28300M -130.70400M -130.70400M
Preferred stock and other adjustments - - - - -
Breakdown 2023-09-30 2022-09-30 2022-08-31 2021-09-30 2021-08-31
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2022-08-31 2021-09-30 2021-08-31
Total assets 298.45M 577.11M 577.11M 554.02M 554.02M
Intangible assets 10.62M 14.26M 14.26M 2.73M 2.73M
Earning assets - - - - -
Other current assets 11.00M 8.36M 8.36M 6.96M 6.96M
Total liab 26.83M 69.05M 69.05M 74.21M 74.21M
Total stockholder equity 271.62M 508.06M 508.06M 479.81M 479.81M
Deferred long term liab - 0.03M 0.03M 0.00700M 0.00700M
Other current liab 1.24M 10.98M 13.43M 2.75M 2.75M
Common stock 776.91M 769.73M 769.73M 730.80M 730.80M
Capital stock - 769.73M 769.73M 730.80M 730.80M
Retained earnings -538.52800M -289.92700M -289.92700M -275.64400M -275.64400M
Other liab - 11.40M 11.40M 43.06M 43.06M
Good will - 41.98M 41.98M 14.32M 14.32M
Other assets 0.00000M 33.14M 33.14M 35.39M 35.39M
Cash 33.86M 68.52M 68.52M 55.37M 55.37M
Cash and equivalents - - - - -
Total current liabilities 22.43M 55.28M 55.28M 26.27M 26.27M
Current deferred revenue 0.09M 2.44M - - -
Net debt -29.14500M -65.15800M -65.15800M -50.40400M -50.40400M
Short term debt 1.09M 1.00M 1.00M 0.08M 0.08M
Short long term debt - 0.08M 0.08M 0.08M 0.08M
Short long term debt total 4.72M 3.36M 3.36M 4.96M 4.96M
Other stockholder equity - 28.26M 28.26M 24.65M 24.65M
Property plant equipment - 259.82M 259.82M 235.94M 235.94M
Total current assets 155.98M 221.62M 221.62M 260.62M 260.62M
Long term investments - 7.07M 7.07M 6.11M 6.11M
Net tangible assets - 451.82M 451.82M 462.76M 462.76M
Short term investments - 30.40M 30.40M 128.48M 128.48M
Net receivables 30.16M 46.07M 46.07M 21.00M 21.00M
Long term debt - 0.15M 0.15M 0.23M 0.23M
Inventory 80.95M 68.28M 68.28M 48.82M 48.82M
Accounts payable 20.01M 40.86M 40.86M 23.44M 23.44M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 33.24M 28.26M 28.26M 24.65M 24.65M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.61M 32.36M 32.36M 31.11M 34.30M
Deferred long term asset charges - - - - -
Non current assets total 142.48M 355.48M 355.48M 293.40M 293.40M
Capital lease obligations - 3.12M 3.12M 4.65M 4.65M
Long term debt total - 2.36M 2.36M 4.88M 4.88M
Breakdown 2023-09-30 2022-09-30 2022-08-31 2021-09-30 2021-08-31
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2022-08-31 2021-09-30 2021-08-31
Investments - 95.47M 95.47M -72.48700M -72.48700M
Change to liabilities - 12.15M 12.15M 2.06M 2.06M
Total cashflows from investing activities - 44.03M 44.03M -115.10900M -115.10900M
Net borrowings - -1.01300M -1.01300M -116.40300M -116.40300M
Total cash from financing activities -0.81700M 5.33M 5.33M 174.46M 174.46M
Change to operating activities - 1.21M 1.21M -0.54200M -0.54200M
Net income -229.47861M -14.28300M -14.28300M -130.70400M -130.70400M
Change in cash -34.65100M 13.15M 13.15M 30.77M 30.77M
Begin period cash flow 68.52M 55.37M 55.37M 24.60M 24.60M
End period cash flow 33.86M 68.52M 68.52M 55.37M 55.37M
Total cash from operating activities -35.18900M -36.21100M -36.21100M -28.58900M -28.58900M
Issuance of capital stock - 0.00000M 0.00000M 284.88M 284.88M
Depreciation 24.17M 24.91M 24.91M 31.03M 31.03M
Other cashflows from investing activities - 5.78M 5.78M -30.32700M -30.32700M
Dividends paid - 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory - -12.21800M -12.21800M 28.68M 28.68M
Change to account receivables 12.51M -24.02000M -24.02000M -6.00700M -6.00700M
Sale purchase of stock - 6.43M 6.43M 228.42M 228.42M
Other cashflows from financing activities -0.75415M -0.08500M 6.34M 5.99M 5.99M
Change to netincome - -23.95800M -23.95800M 55.82M 55.82M
Capital expenditures 30.43M 48.78M 48.78M 12.33M 12.33M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -5.51600M -22.87700M -22.87700M 24.20M 24.20M
Stock based compensation 5.29M 5.13M 5.13M 3.90M 3.90M
Other non cash items 227.60M -28.99700M -28.99700M 0.78M 42.99M
Free cash flow -65.61700M -84.98900M -84.98900M -40.91800M -40.91800M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OGI
OrganiGram Holdings Inc
0.06 3.87% 1.61 - 14.58 1.57 0.79 0.96 -1.4157
BHC
Bausch Health Companies Inc
-0.14 2.13% 6.42 - 2.23 0.50 18.74 2.56 9.13
CURA
Curaleaf Holdings Inc.
-0.05 4.13% 1.16 - 138.89 1.62 1.66 1.73 10.18
TLRY
Tilray Inc
-0.01 1.64% 0.60 - 1000.00 2.17 0.36 1.69 -2.299
CRON
Cronos Group Inc
0.01 0.54% 2.79 - - 10.18 0.70 0.02 -1.9458

Reports Covered

Stock Research & News

Profile

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

OrganiGram Holdings Inc

145 King Street West, Toronto, ON, Canada, M5H 1J8

Key Executives

Name Title Year Born
Mr. Derrick W. West CPA, CPA, (CA) Chief Financial Officer 1967
Ms. Helen Martin Chief Legal Officer & Corp. Sec. 1978
Mr. Gregory Engel Special Advisor 1965
Mr. Timothy Emberg Chief Revenue Officer NA
Mr. Paolo De Luca C.A., C.F.A Chief Strategy Officer 1973
Ms. Beena G. Goldenberg CEO & Director 1963
Ms. Nathalie Batten VP of Operations NA
Mr. Geoff Riggs Chief Information Officer NA
Amy Schwalm VP of Investor Relations NA
Ms. Megan Amber McCrae Sr. VP of Marketing & Communications NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.